Skip to main content
. 2023 Mar 13;3(4):391–401. doi: 10.1038/s43587-023-00380-7

Extended Data Table 4.

CSF tau measures for the Knight ADRC amyloid PET cohort

graphic file with name 43587_2023_380_Tab4_ESM.jpg

Continuous values are presented as the median with the IQR. The significance of differences by amyloid PET status was evaluated with Wilcoxon’s rank-sum tests for continuous variables and χ2 or Fisher’s exact test for categorical variables. The fold difference is the median biomarker value in the amyloid PET-positive group divided by the median value in the amyloid PET-negative group. All tests were two sided and not adjusted for multiple comparisons.